KCC2 determines the polarity and efficacy of GABAA and glycine receptors, and pathologies that derive from a KCC2 deficiency cause neural excitability-related disorders, such as epilepsy and Huntington’s disease (Tang 2020). The gene discussed is SLC12A5; the disease is epilepsy.